FDA Panel Reviewing Pfizer Clinical Trial For Children 5 and Up

On October 26, a Food and Drug Administration advisory panel is set to vote on whether to authorize a recommendation of vaccines for children ages 5-11

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting